Neurofilament Light Chain as Axonal Cytoskeleton Component
Placeholder: NfL is a core structural protein of the axonal cytoskeleton.
- Type IV IF: Protein class (intermediate filament placeholder)
- Axon: Location (cytoskeletal scaffold placeholder)
- NfM / NfH: Partners (neurofilament triplet placeholder)
- Axon caliber: Function (structural support placeholder)
Structural role placeholder heading
Placeholder text describing neurofilament light chain structural function in axons.
Release of NfL Into Blood Upon Axonal Injury
Placeholder: axonal damage releases NfL into CSF and blood.
- Axon injury: Release trigger (placeholder mechanism)
- CSF → blood: Compartment (placeholder pathway)
- ~weeks: Half-life (placeholder kinetics)
- Simoa assay: Detection (placeholder method)
Release mechanism placeholder heading
Placeholder text describing NfL release kinetics after axonal damage.
NfL as a Broad Neurodegeneration Marker
Placeholder: elevated NfL reflects neuronal damage broadly, not one disease.
- Many: Conditions (broad marker placeholder)
- Low: Specificity (disease-non-specific placeholder)
- High: Sensitivity (damage detection placeholder)
- Screening: Use (general indicator placeholder)
Specificity limitation placeholder heading
Placeholder text describing why NfL elevation is non-specific across neurodegenerative diseases.
Differentiating Alzheimer's Disease From Other Neurodegeneration
Placeholder: NfL must be combined with other markers for diagnosis.
- Aβ42/40, p-tau: Companion markers (placeholder panel)
- Limited: AD specificity alone (placeholder note)
- Improved: Combined panels (placeholder accuracy)
- FTD, ALS, MS: Overlap conditions (placeholder list)
Differential diagnosis placeholder heading
Placeholder text describing combined biomarker panels for Alzheimer's differentiation.
Serial NfL Monitoring for Disease Progression
Placeholder: repeated NfL measurement tracks progression and therapy response.
- Months: Monitoring interval (serial sampling placeholder)
- High: Trend value (longitudinal utility placeholder)
- Trackable: Therapy response (placeholder application)
- Endpoint: Trial use (clinical trial placeholder)
Longitudinal tracking placeholder heading
Placeholder text describing serial NfL monitoring for progression tracking.
Placeholder key insight about trend-based clinical value of serial NfL testing.